---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-219415"
form_type: "8-K"
ticker: "LMRI"
cik: "0002071288"
company_name: "Lumexa Imaging Holdings, Inc."
filed_at: "2026-05-12T20:08:46+00:00"
generated_at: "2026-05-12T21:23:44.680906+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lumexa Q1 rev $252.5M (+3.1%); net income $1.7M vs loss; reaffirms FY guidance

## Summary
- Consolidated revenues of $252.5M, up 3.1% YoY; net income $1.7M vs net loss of $7.7M.
- GAAP EPS $0.02; Adjusted EPS $0.18; Adjusted EBITDA $51.2M (20.3% margin) vs $51.0M.
- Same-center advanced volume growth of 5.6% for both consolidated and system-wide.
- Announced four new centers: two tuck-in acquisitions and two de novos; on track for 8-10 de novos in 2026.
- FY 2026 guidance reaffirmed: rev $1.045-1.097B, Adj EBITDA $234-242M, Adj EPS $0.71-0.77.

## SEC filing metadata
- accession: 0001193125-26-219415
- form_type: 8-K
- ticker: LMRI
- cik: 0002071288
- company_name: Lumexa Imaging Holdings, Inc.
- filed_at: 2026-05-12T20:08:46+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/0001193125-26-219415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/d145661d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-219415
- JSON: https://secwatch.observer/filing/0001193125-26-219415.json
- Plain text: https://secwatch.observer/filing/0001193125-26-219415.txt

## Key facts
- Earnings Releases
  Lumexa Imaging Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $252.5 million, net income $1.7 million, EPS $0.02 per share. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $252.5 million
  - Net income: $1.7 million
  - EPS: $0.02 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: for patients, providers, and payors.” First Quarter 2026 Highlights: All comparisons are to the quarter ended March 31, 2025, unless otherwise noted • Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million • System-wide revenue growth of 4.0% • Same center advanced volume growth: 5.6% for both consolidated and system-wide • Net income of
  evidence_url: https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/0001193125-26-219415-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.